Carboplatin	carboplatin	S_chemical	O
toxic	toxic	O	O
effects	effects	O	O
on	on	O	O
the	the	O	O
peripheral	peripheral	O	O
nervous	nervous	O	O
system	system	O	O
of	of	O	O
the	the	O	O
rat	rat	O	O
.	.	O	O

BACKGROUND	background	O	O
:	:	O	O
The	the	O	O
most	most	O	O
striking	striking	O	O
of	of	O	O
carboplatin	carboplatin	S_chemical	O
's	's	O	O
advantages	advantages	O	O
(	(	O	O
CBDCA	cbdca	O	O
)	)	O	O
over	over	O	O
cisplatin	cisplatin	S_chemical	O
(	(	O	O
CDDP	cddp	O	O
)	)	O	O
is	is	O	O
its	its	O	O
markedly	markedly	O	O
reduced	reduced	O	O
rate	rate	O	O
of	of	O	O
neurotoxic	neurotoxic	O	S_disease
effects	effects	O	O
.	.	O	O

However	however	O	O
,	,	O	O
the	the	O	O
use	use	O	O
of	of	O	O
CBDCA	cbdca	O	O
higher-intensity	higher-intensity	O	O
schedules	schedules	O	O
and	and	O	O
the	the	O	O
association	association	O	O
with	with	O	O
other	other	O	O
neurotoxic	neurotoxic	O	S_disease
drugs	drugs	O	O
in	in	O	O
polychemotherapy	polychemotherapy	O	O
may	may	O	O
cause	cause	O	O
some	some	O	O
concern	concern	O	O
about	about	O	O
its	its	O	O
safety	safety	O	O
with	with	O	O
respect	respect	O	O
to	to	O	O
peripheral	peripheral	O	O
nervous	nervous	O	O
system	system	O	O
damage	damage	O	O
.	.	O	O

MATERIALS	materials	O	O
AND	and	O	O
METHODS	methods	O	O
:	:	O	O
Two	two	O	O
different	different	O	O
schedules	schedules	O	O
of	of	O	O
CBDCA	cbdca	O	O
administration	administration	O	O
(	(	O	O
10	10	O	O
mg/kg	mg/kg	O	O
and	and	O	O
15	15	O	O
mg/kg	mg/kg	O	O
i.p	i.p	O	O
.	.	O	O
twice	twice	O	O
a	a	O	O
week	week	O	O
for	for	O	O
nine	nine	O	O
times	times	O	O
)	)	O	O
were	were	O	O
evaluated	evaluated	O	O
in	in	O	O
Wistar	wistar	O	O
rats	rats	O	O
.	.	O	O

Neurotoxicity	neurotoxicity	O	S_disease
was	was	O	O
assessed	assessed	O	O
for	for	O	O
behavioral	behavioral	O	O
(	(	O	O
tail-flick	tail-flick	O	O
test	test	O	O
)	)	O	O
,	,	O	O
neurophysiological	neurophysiological	O	O
(	(	O	O
nerve	nerve	O	O
conduction	conduction	O	O
velocity	velocity	O	O
in	in	O	O
the	the	O	O
tail	tail	O	O
nerve	nerve	O	O
)	)	O	O
,	,	O	O
morphological	morphological	O	O
,	,	O	O
morphometrical	morphometrical	O	O
and	and	O	O
analytical	analytical	O	O
effects	effects	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
CBDCA	cbdca	O	O
administration	administration	O	O
induced	induced	O	O
dose-dependent	dose-dependent	O	O
peripheral	peripheral	O	O
neurotoxicity	neurotoxicity	O	S_disease
.	.	O	O

Pain	pain	O	S_disease
perception	perception	O	O
and	and	O	O
nerve	nerve	O	O
conduction	conduction	O	O
velocity	velocity	O	O
in	in	O	O
the	the	O	O
tail	tail	O	O
were	were	O	O
significantly	significantly	O	O
impaired	impaired	O	O
,	,	O	O
particularly	particularly	O	O
after	after	O	O
the	the	O	O
high-dose	high-dose	O	O
treatment	treatment	O	O
.	.	O	O

The	the	O	O
dorsal	dorsal	O	O
root	root	O	O
ganglia	ganglia	O	O
sensory	sensory	O	O
neurons	neurons	O	O
and	and	O	O
,	,	O	O
to	to	O	O
a	a	O	O
lesser	lesser	O	O
extent	extent	O	O
,	,	O	O
satellite	satellite	O	O
cells	cells	O	O
showed	showed	O	O
the	the	O	O
same	same	O	O
changes	changes	O	O
as	as	O	O
those	those	O	O
induced	induced	O	O
by	by	O	O
CDDP	cddp	O	O
,	,	O	O
mainly	mainly	O	O
affecting	affecting	O	O
the	the	O	O
nucleus	nucleus	O	O
and	and	O	O
nucleolus	nucleolus	O	O
of	of	O	O
ganglionic	ganglionic	O	O
sensory	sensory	O	O
neurons	neurons	O	O
.	.	O	O

Moreover	moreover	O	O
,	,	O	O
significant	significant	O	O
amounts	amounts	O	O
of	of	O	O
platinum	platinum	O	O
were	were	O	O
detected	detected	O	O
in	in	O	O
the	the	O	O
dorsal	dorsal	O	O
root	root	O	O
ganglia	ganglia	O	O
and	and	O	O
kidney	kidney	O	O
after	after	O	O
CBDCA	cbdca	O	O
treatment	treatment	O	O
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
CBDCA	cbdca	O	O
is	is	O	O
neurotoxic	neurotoxic	O	S_disease
in	in	O	O
our	our	O	O
model	model	O	O
,	,	O	O
and	and	O	O
the	the	O	O
type	type	O	O
of	of	O	O
pathological	pathological	O	O
changes	changes	O	O
it	it	O	O
induces	induces	O	O
are	are	O	O
so	so	O	O
closely	closely	O	O
similar	similar	O	O
to	to	O	O
those	those	O	O
caused	caused	O	O
by	by	O	O
CDDP	cddp	O	O
that	that	O	O
it	it	O	O
is	is	O	O
probable	probable	O	O
that	that	O	O
neurotoxicity	neurotoxicity	O	S_disease
is	is	O	O
induced	induced	O	O
in	in	O	O
the	the	O	O
two	two	O	O
drugs	drugs	O	O
by	by	O	O
the	the	O	O
same	same	O	O
mechanism	mechanism	O	O
.	.	O	O

This	this	O	O
model	model	O	O
can	can	O	O
be	be	O	O
used	used	O	O
alone	alone	O	O
or	or	O	O
in	in	O	O
combination	combination	O	O
with	with	O	O
other	other	O	O
drugs	drugs	O	O
to	to	O	O
explore	explore	O	O
the	the	O	O
effect	effect	O	O
of	of	O	O
CBDCA	cbdca	O	O
on	on	O	O
the	the	O	O
peripheral	peripheral	O	O
nervous	nervous	O	O
system	system	O	O
.	.	O	O

